Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Anemia and ERCC1[original query] |
|---|
| Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients. The pharmacogenomics journal 2010 Feb 10 (1): 54-61. Khrunin A V, Moisseev A, Gorbunova V, Limborska |
| Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jul 27 (21): 3540-6. Gandara David R, Kawaguchi Tomoya, Crowley John, Moon James, Furuse Kiyoyuki, Kawahara Masaaki, Teramukai Satoshi, Ohe Yuichiro, Kubota Kaoru, Williamson Stephen K, Gautschi Oliver, Lenz Heinz Josef, McLeod Howard L, Lara Primo N, Coltman Charles Arthur, Fukuoka Masahiro, Saijo Nagahiro, Fukushima Masanori, Mack Philip |
| Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins. Pharmacogenomics 2011 Dec . Khrunin A, Ivanova F, Moisseev A, Khokhrin D, Sleptsova Y, Gorbunova V, Limborska S |
| Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients. Clinical lung cancer 2014 Nov 15 (6): 455-65. Powrózek Tomasz, Kowalski Dariusz M, Krawczyk Pawe?, Ramlau Rodryg, Kucharczyk Tomasz, Kalinka-Warzocha Ewa, Knetki-Wróblewska Magdalena, Winiarczyk Kinga, Dyszkiewicz Wojciech, Krzakowski Maciej, Milanowski Janu |
| Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients. Journal of cancer research and clinical oncology 2014 Dec 140 (12): 2047-57. Krawczyk Pawe?, Kucharczyk Tomasz, Kowalski Dariusz M, Powrózek Tomasz, Ramlau Rodryg, Kalinka-Warzocha Ewa, Winiarczyk Kinga, Knetki-Wróblewska Magdalena, Wojas-Krawczyk Kamila, Ka?akucka Katarzyna, Dyszkiewicz Wojciech, Krzakowski Maciej, Milanowski Janu |
| SNPs and taxane toxicity in breast cancer patients. Pharmacogenomics 2014 15 (15): 1845-58. Bosó Virginia, Herrero María José, Santaballa Ana, Palomar Laura, Megias Juan E, de la Cueva Helena, Rojas Luis, Marqués María Remedios, Poveda José Luis, Montalar Joaquin, Aliño Salvador |
| Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer. BMC pharmacology & toxicology 2015 16 2. Lambrechts Sandrina, Lambrechts Diether, Despierre Evelyn, Van Nieuwenhuysen Els, Smeets Dominiek, Debruyne Philip R, Renard Vincent, Vroman Philippe, Luyten Daisy, Neven Patrick, Amant Frédéric, Leunen Karin, Vergote Ignace, |
| Clinical research of individualized therapy in advanced esophageal cancer based on the ERCC1 C8092A genotype. Oncology letters 2018 Aug 16 (2): 2539-2548. Yao Yi-Wei, He Yi-Fu, Han Xing-Hua, Ji Chu-Shu, Hu Bi |
| Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018 Feb 9 (10): 9114-9136. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E |
| Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients. Frontiers in pharmacology 2019 10 206. Lavanderos María A, Cayún Juan P, Roco Ángela, Sandoval Christopher, Cerpa Leslie, Rubilar Juan C, Cerro Roberto, Molina-Mellico Sebastián, Celedón Cesar, Cerda Berta, García-Martín Elena, Agúndez José A G, Acevedo Cristián, Peña Karina, Cáceres Dante D, Varela Nelson M, Quiñones Luis |
| Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh. Molecular biology reports 2020 Sep . Bushra Most Umme, Rivu Sanzana Fareen, Sifat Ali Ehsan, Nahid Noor Ahmed, Ahmed Maizbha Uddin, Al-Mamun Mir Md Abdullah, Apu Mohd Nazmul Hasan, Islam Md Siddiqul, Islam Md Reazul, Islam Mohammad Safiqul, Hasnat Ab |
| ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy. Asian Pacific journal of cancer prevention : APJCP 2020 Jul 21 (7): 1925-1929. Liblab Salisa, Vusuratana Apichai, Areepium Nuttha |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: